urea has been researched along with Benign Cerebellar Neoplasms in 4 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Lawson, C | 1 |
Ahmed Alta, TB | 1 |
Moschou, G | 1 |
Skamnaki, V | 1 |
Solovou, TGA | 1 |
Topham, C | 1 |
Hayes, J | 1 |
Snape, TJ | 1 |
Prince, EW | 1 |
Balakrishnan, I | 1 |
Shah, M | 1 |
Mulcahy Levy, JM | 1 |
Griesinger, AM | 1 |
Alimova, I | 1 |
Harris, PS | 1 |
Birks, DK | 1 |
Donson, AM | 1 |
Davidson, N | 1 |
Remke, M | 1 |
Taylor, MD | 1 |
Handler, MH | 1 |
Foreman, NK | 1 |
Venkataraman, S | 1 |
Vibhakar, R | 1 |
URCIUOLI, R | 1 |
SATO, R | 1 |
4 other studies available for urea and Benign Cerebellar Neoplasms
Article | Year |
---|---|
Novel diarylamides and diarylureas with N-substitution dependent activity against medulloblastoma.
Topics: Amides; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cerebellar Neoplasms; Dose-Resp | 2021 |
Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzodiazepinones; Biomarkers, Tumor; Cel | 2016 |
[A NEW OSMOTIC DRUG: HYPERTONIC SOLUTION OF MANNITOL. ADVANTAGES AS COMPARED WITH UREA. USE IN THE TREATMENT OF ASEPTIC SEROUS MENINGITIS AND POSTOPERATIVE CEREBROSPINAL FLUID FISTULAS].
Topics: Brain Neoplasms; Cerebellar Neoplasms; Cochlear Nerve; Ependymoma; Fistula; Glioma; Hypertonic Solut | 1963 |
[CLINICAL STUDIES ON INTRACRANIAL PRESSURE-LOWERING AGENTS WITH SPECIAL REFERENCE TO HYPERTONIC UREA SOLUTION. 2].
Topics: Adolescent; Brain Edema; Brain Neoplasms; Cerebellar Neoplasms; Child; Craniocerebral Trauma; Cranio | 1964 |